165 results match your criteria: "Royal Cancer Hospital[Affiliation]"
Clinics (Sao Paulo)
September 2024
Department of Endoscope, Tongren Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:
Background: Circular RNAs (circRNAs) hold critical importance due to their notable function in developing Gastric Cancer (GC), which is a malignancy with the third most frequent occurrence worldwide. The aim of this study was to see if circRNA_0044516 would control GC cell proliferation and establish more effective therapeutic strategies.
Methods: In GC tissues or cells, quantitative Real‑Time Polymerase Chain Reaction (qRT-PCR) was employed for the detection of the expression of circRNA_100349, Insulin-like Growth Factor II (IGF2), and miR-218-5p.
Expert Opin Ther Targets
March 2024
Department of Oncology, University of Turin, Orbassano (TO), Italy.
Introduction: Soft tissue sarcomas are a group of rare, mesenchymal tumors characterized by dismal prognosis in advanced/metastatic stages. Knowledge of their molecular determinants is still rather limited. However, in recent years, epigenetic regulation - the modification of gene expression/function without DNA sequence variation - has emerged as a key player both in sarcomagenesis and sarcoma progression.
View Article and Find Full Text PDFCancer Rep (Hoboken)
February 2023
Department of Gynaecology and Obstetrics, Division of Gynaecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Breast Cancer Res Treat
January 2023
Centre for Health Economics, University of York, Heslington, UK.
Purpose: We estimated the cost-effectiveness of 4 radiotherapy modalities to treat early breast cancer in the UK. In a subgroup of patients eligible for all modalities, we compared whole-breast (WB) and partial breast (PB) radiotherapy delivered in either 15 (WB15F, PB15F) or 5 fractions (WB5F, PB5F). In a subgroup ineligible for PB radiotherapy, we compared WB15F to WB5F.
View Article and Find Full Text PDFNat Commun
November 2020
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Chromatin structure is dynamically reorganized at multiple levels in response to DNA double-strand breaks (DSBs). Yet, how the different steps of chromatin reorganization are coordinated in space and time to differentially regulate DNA repair pathways is insufficiently understood. Here, we identify the Chromodomain Helicase DNA Binding Protein 7 (CHD7), which is frequently mutated in CHARGE syndrome, as an integral component of the non-homologous end-joining (NHEJ) DSB repair pathway.
View Article and Find Full Text PDFInt Orthop
August 2020
Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Background: Detection of COVID-19 cases' accuracy is posing a conundrum for scientists, physicians, and policy-makers. As of April 23, 2020, 2.7 million cases have been confirmed, over 190,000 people are dead, and about 750,000 people are reported recovered.
View Article and Find Full Text PDFBMJ
September 2016
Centre for Health Economics, University of York, York, UK.
Sarcoma
July 2016
Herlev University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark.
Background. Belinostat is a novel histone deacetylase inhibitor. Primary Objectives.
View Article and Find Full Text PDFLeukemia
August 2016
Hematology Laboratory, Nantes University Hospital, Nantes, France.
Int J Radiat Oncol Biol Phys
March 2016
Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Several recent developments in linear accelerator-based radiation therapy (RT) such as fast multileaf collimators, accelerated intensity modulation paradigms like volumeric modulated arc therapy and flattening filter-free (FFF) high-dose-rate therapy have dramatically shortened the duration of treatment fractions. Deliverable photon dose distributions have approached physical complexity limits as a consequence of precise dose calculation algorithms and online 3-dimensional image guided patient positioning (image guided RT). Simultaneously, beam quality and treatment speed have continuously been improved in particle beam therapy, especially for scanned particle beams.
View Article and Find Full Text PDFAnn Oncol
May 2015
Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France.
Background: Using surrogate end points for overall survival, such as disease-free survival, is increasingly common in randomized controlled trials. However, the definitions of several of these time-to-event (TTE) end points are imprecisely which limits interpretation and cross-trial comparisons. The estimation of treatment effects may be directly affected by the definitions of end points.
View Article and Find Full Text PDFAnn Intensive Care
January 2015
Servie de Réanimation Polyvalente, Centre de Réanimation, Hôpital Roger Salengro, CHRU, 2 Avenue Oscar Lambret, Lille Cedex 59037, France.
Background: Even in developed countries, severe specific pregnancy complications may occur in the immediate postpartum period and require admission to the ICU. The characteristics and risk factors of acute renal failure (ARF) induced by these complications and their treatments are not well known.
Methods: We performed a retrospective multicenter study in three intensive care departments linked to level III maternity wards in the north of France.
Clin Cancer Res
February 2014
Authors' Affiliations: National Cancer Institute, NIH, Center for Cancer Research, Medical Oncology Branch, Bethesda, Maryland; and The Institute of Cancer Research, Royal Cancer Hospital, London, United Kingdom.
Since the mid-1990s, the multiple myeloma treatment landscape has evolved considerably, which has led to improved patient outcomes and prolonged survival. In addition to discovering new, targeted agents or treatment regimens, the identification and validation of biomarkers has the potential to further improve patient outcomes. The International Staging System relies on a number of biochemical parameters to stratify patients into risk categories.
View Article and Find Full Text PDFClin Lymphoma Myeloma Leuk
February 2014
The Institute of Cancer Research, Royal Cancer Hospital, London, UK.
Background: VSLI (Marqibo) is active in advanced non-Hodgkin lymphoma (NHL) and untreated aggressive NHL. Because of its favorable hematologic toxicity profile, VSLI might be useful in patients unable to tolerate myelosuppressive therapies.
Patients And Methods: Twenty-two patients with heavily pretreated, advanced CD20(+) DLBCL or MCL were treated with VSLI 2.
Methods Mol Biol
June 2011
Breakthrough Centre, The Institute of Cancer Research, Royal Cancer Hospital, London, UK.
Multiple immunofluorescent labeling of formalin-fixed paraffin-embedded (FFPE) tissue is not a routinely used method. At least in part, this is due to the perception that the innate autofluorescence of the FFPE material forbids the use of immunofluorescent labeling. As a result, immunohistochemical (immunoperoxidase) staining of FFPE material or cryosectioning methods is used instead.
View Article and Find Full Text PDFMethods Mol Biol
January 2011
Royal Cancer Hospital Cancer Genetics, Sutton, Surrey, London, UK.
Tissue microarray (TMA) technology is a robust "high throughput" method of tissue analysis, whereby a large number of patient samples can be examined in a short time using a minimum number of slides. In a TMA, cylinders of tissue are cored out of formalin-fixed, paraffin-embedded tissue blocks and slotted in a regular grid pattern into a blank recipient paraffin wax block. The TMA block is then cut using a standard laboratory microtome.
View Article and Find Full Text PDFEur J Cancer
May 2009
Department of Medicine, Centre Leon Berard, 28, rue Laennec, 69008 Lyon, France. Electronic address:
IDrugs
November 2001
The Institute of Cancer Research: Royal Cancer Hospital, 123 Old Brompton Road, London, SW7 3RP, UK.
This meeting formed part of a series of bi-annual conferences, which had its beginnings in Sardinia in 1985, with the goal of promoting the concept of differentiation induction in cancer therapy. As in the past, the organizers of this meeting aimed to bring together both basic and clinical investigators to promote their interaction. Therapeutic successes of all trans-retinoic acid (ATRA), arsenic trioxide and STI-571 have proven the importance of oncogene-targeted therapies in cancer treatment, and underlie the usefulness of such interactions for effective and rational design of therapeutic approaches to combat malignant diseases.
View Article and Find Full Text PDFJ Neurol Sci
March 1999
Department of Radiation Research, The Institute of Cancer Research, Royal Cancer Hospital, Sutton, UK.
Oxidative stress may play a role in the pathogenesis of familial amyotrophic lateral sclerosis (FALS). Superoxide dismutases (SODs) are enzymes that can influence free radical processes in irradiated cells and there is some evidence that manipulation of SODs can affect survival of cells after radiation treatments. SOD-1 associated FALS mutants may have an altered radiation response due to an enhanced generation of hydroxyl radicals or a compromised ability to neutralize free radicals.
View Article and Find Full Text PDFIn Vitro Cell Dev Biol Anim
October 1998
Section of Cell Biology and Experimental Pathology, Institute of Cancer Research: Royal Cancer Hospital, Sutton, Surrey, United Kingdom.
Lineage analysis in vitro of heterogeneous tissues such as mammary epithelium requires the separation of constituent cell types and their growth as clones. The separation of virgin mouse mammary luminal epithelial and myoepithelial cells by fluorescence-activated cell-sorting, their growth at clonal density, and the phenotyping of the clones obtained with cell-type specific markers are described in this paper. Epithelial cells were isolated by collagenase digestion followed by trypsinization, and the luminal and myoepithelial cells were flow-sorted with the rat monoclonal antibodies 33A10 and JB6, respectively.
View Article and Find Full Text PDFJ Med Chem
September 1998
Section of Molecular Carcinogenesis and Cancer Research Campaign Biomolecular Structure Unit, The Institute of Cancer Research, Royal Cancer Hospital, Sutton, Surrey SM2 5NG, UK.
Fifteen anthracene-9,10-dione ("anthraquinone") derivatives with (omega-aminoalkyl)carboxamido substituents at the 1-, 2-, 1,4-, or 2, 6-ring positions were tested for bacterial mutagenicity in reverse-mutation assays using Salmonella typhimurium frameshift strains TA1538, TA98, and TA97a, in the presence and absence of a metabolic activation system prepared from the livers of rats treated with Aroclor 1254. Six of the compounds were also tested in S. typhimurium TA100 and Escherichia coli WP2uvrApKM101 strains, which carry mutations particularly sensitive to reversion by DNA base-pair substitution.
View Article and Find Full Text PDFBr J Surg
July 1998
Section of Molecular Carcinogenesis, Institute of Cancer Research, Royal Cancer Hospital, Harrow, UK.
Background: Telomerase activity may be required for unlimited growth of cells and is repressed in most somatic tissues, but is detectable in immortal cell lines, germ cells, many malignancies and some benign lesions. Desmoids are proliferative, locally invasive, non-metastasizing fibromatous tumours which rarely regress. They occur frequently in familial adenomatous polyposis (FAP), causing significant morbidity and death.
View Article and Find Full Text PDFMutat Res
August 1997
Section of Molecular Carcinogenesis, Institute of Cancer Research, Royal Cancer Hospital, Sutton, Surrey, UK.
32P-postlabelling is a highly sensitive technique for the detection of DNA adducts. It is unique in that it requires no prior knowledge of the nature of adducts or adduct-forming species under investigation. In the past, we have used this technique to investigate the role of bile in the production of foregut adenomas in patients with familial adenomatous polyposis (FAP).
View Article and Find Full Text PDFBr J Urol
August 1997
Section of Molecular Carcinogenesis, Institute of Cancer Research, Royal Cancer Hospital, Sutton, UK.
Objective: To assess the role of telomerase activity as a marker for the development of prostate cancer in men with existing benign prostatic hyperplasia (BPH), a known risk factor for prostatic carcinoma.
Materials And Methods: Telomerase activity was assayed, using a highly sensitive polymerase-chain reaction-based assay, in nine biopsies from patients with prostatic cancer, 16 from patients clinically diagnosed with BPH and 11 from patients with no evidence of prostatic disease.
Results: Telomerase activity was detectable in eight of the nine prostate cancer biopsies, in none of the normal prostates and in six of the 16 BPH biopsies.
Br J Cancer
December 1996
Cancer Research Campaign Centre for Cancer Therapeutics, Institute of Cancer Research: Royal Cancer Hospital, Sutton, UK.
We have used flow cytometry to study the mechanism of cytotoxic action of a series of ammine/amine Pt(IV) dicarboxylates [ammine diacetatodichloro(cyclohexylamine) platinum(IV), JM216; ammine dibutyratodichloro(cyclohexylamine)platinum(IV), JM221; ammine diacetatodichloro(propylamine)platinum(IV), JM223; ammine dibenzoatodichloro(propylamine)platinum(IV), JM244]. JM216 has been shown to have clinical potential and has recently entered phase II trials. All the compounds caused a slowdown in S-phase transit followed by a block in G2.
View Article and Find Full Text PDF